.png){kind=icon}
.png){kind=icon}
Return
Trends and Disparities in CAR-T Therapy Utilization, Inpatient Mortality, Length of Stay, and Costs in the United States (2017–2022)
.png){kind=icon}
OA
AI
S
P
T
Y
X
S
S
Y
S
M
V
R
DOI：10.1016/j.jtct.2026.06.022.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
• CAR-T therapy utilization increased 67-fold in the US from 2017 to 2022. • Utilization expanded notably among older adults and multiple myeloma patients. • Racial, income, and insurance-based disparities in CAR-T access persist. • Inpatient length of stay declined while hospitalization costs rose significantly. • Supportive biologics including tocilizumab use increased.
Keywords:
CAR-T therapy
Trend
Multiple myeloma
Disparities
Hospitalization cost
Length of stay
Inpatient mortality
National Inpatient Sample
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
4.4
Papers:
2.1K
Citations:
4.4K
Organization
Cited Papers